CX3CR1 and Parkinson disease: Castro-Sánchez et al. (2018) suggest that CX3CR1 signaling may exert a protective effect against neuroinflammation and neurodegeneration in PD, particularly in relation to alpha-synuclein pathology, a characteristic feature of the disease.